One intervention, many ways to explain risks
From the February ACP Internist, copyright © 2008 by the American College of Physicians.
By Stacey Butterfield
Which of these drugs would you be most likely to take—one that prevents a heart attack in one out of 13 patients taking the drug, one that postpones a heart attack for two months in all patients, or one that postpones a heart attack for eight months in one out of four patients?
When researcher Peder A. Halvorsen, MD, asked a similar question of 1,754 Norwegian patients, he wondered whether most patients would opt for the scenario that gave them the certain benefit of postponing disease. In fact, his study, published in the June 19, 2007 Annals of Internal Medicine, found that patients were most likely to agree to the drug when told that it prevented heart attacks in one in 13 patients, known as the number-needed-to-treat (NNT) format.
“In my opinion, the most interesting thing about this study is that these different ways of explaining things may matter to lay people,” said Dr. Halvorsen. In fact, the differences mattered quite a lot. The rate of patients consenting to treatment varied from 93% in the NNT group to 69% in those who were told about the two-month postponement for all patients.
The findings of Dr. Halvorsen’s study point out both the importance and the challenges of communicating with patients about risk. While it may be difficult for physicians to decide on the way to explain statistical concepts to patients, it’s clear that the explanation they choose greatly affects the way patients respond.
The dilemma is a fairly new one in medicine, but in recent years a smattering of researchers have begun working to uncover the best possible way to explain risk and the statistics that quantify it to patients.
Make it absolute
By studying how patients make both real and hypothetical decisions about medications, screenings and other intervention choices, researchers have come to some general conclusions about effective risk communication.
“The literature would bear out that presenting risk in certain formats is easier to understand and less likely to bias patients. The formats that seem to do better are the absolute risk reduction and relative risk reduction formats,” said Stacey L. Sheridan, ACP Member and assistant professor of medicine at the University of North Carolina.
Both formats use percentages to show patients how an intervention would affect their risk of developing a certain outcome. The difference is that absolute risk quantifies the change in the patient’s risk from the baseline, while relative risk reveals only the change in risk accomplished by the intervention. The net effect is that changes in relative risk tend to be much more dramatic—for example, a reduction in risk from eight out of 100 to four out of 100 is a 50% relative risk reduction, but only a 4% absolute risk reduction.
Both calculations may be easy for patients to understand, but they can have very different effects on their decisions, according to Dr. Sheridan. “Something notable about relative risk reduction is that it’s persuasive. We have showed time and time again that people who are presented with a relative risk reduction format are more likely to choose to take a medication. Doctors who get information on the benefits of a medication in terms of relative risk reduction are more likely to prescribe the medicine,” she said.
For example, consider a case of a woman deciding whether to take adjuvant therapy for breast cancer, said Albert Mulley, MD, chief of general medicine at Massachusetts General Hospital. He described a scenario in which adjuvant therapy reduces the risk of recurrence by 30%. As a relative risk reduction, that sounds significant, but the absolute risk reduction would vary dramatically depending on whether the women’s overall risk of recurrence is 40% or 10%.
“With more and more women with smaller and smaller node-negative tumors being found with mammography, we see lots of women with recurrence risks of well less than 10%, so the 30% reduction is just tiny in the baseline scheme of things,” said Dr. Mulley.
Comprehension, not persuasion
The possibility that some of those low-risk women might choose therapy because they have an exaggerated sense of the benefits concerns Dr. Sheridan. For that reason, she has focused her research on the question of how well patients understand statistics, in addition to how they react to them.
“Most of the studies about risk perception really have looked at persuasiveness. We’ve spent very little time figuring out what people understand,” she said. Her research has found that understanding to be fairly low. In one study, at best only 21% of patients could calculate the effect of a drug on baseline risk of disease.
“Even people who have high levels of education and literacy have trouble with numbers.”
The patients had more success when they were asked to compare the effectiveness of two different interventions. “Even people who have high levels of education and literacy have trouble with numbers,” said Dr. Sheridan. “People do much better at comparative tasks than calculating tasks, so the extent to which we can help them make comparisons, we can help them do better.”
Given the difficulty of explaining statistics to patients, some experts have begun searching for alternative methods to compare individual risks. Steven A. Grover, MD, professor of medicine at McGill University, recently tried out one technique, cardiovascular age, on more than 2,000 Canadian patients.
Patients in the study, which was published in the Archives of Internal Medicine, were told their cardiovascular age (current age minus calculated change in life expectancy based on cardiovascular risk factors) and offered advice on lifestyle changes and pharmacotherapy to treat dyslipidemia. Controls were not told their cardiovascular age.
Although overall the study recorded fairly modest impact on the patients’ achievement of lipid targets, the patients with the greatest difference between their real age and cardiovascular age had significantly larger drops in cholesterol levels than those with the lowest difference. Conversely, those patients whose cardiovascular age was lower than their chronologic age were less likely to get to targets than those receiving usual care, which indicated that risk assessment also served to reassure low-risk individuals, noted Dr. Grover.
“All we know for certain is that low-risk people were less likely to respond to the risk profile,” he said. “People clearly understand when their risk factors are high enough that their cardiovascular age is higher than their chronological age, and when they’ve done something to bring that cardiovascular age down, they know they are going in the right direction,” he added.
After his study was complete, Dr. Grover put the cardiovascular age tool on the Internet at www.chiprehab.com so that interested patients could access it themselves. Such resources (commonly called decision aids) that enable patients to learn more about their risk profile without a physician present may be key to helping patients make good decisions, experts said.
Evidence-based decision aids, which can take the form of picture boards, videos or booklets, can prepare patients for a conversation about their risks and options, a big benefit for time-pressed physicians. “The doctors don’t have to spend as much time. They can spend time answering questions,” said Dr. Sheridan.
Time and office space could be used even more efficiently if decision aids turn out to work as take-home assignments for patients. Dominick L. Frosch, PhD, assistant professor in the UCLA department of medicine, has studied video decision aids used in the office, and someday plans to examine what would happen if physicians prescribed the aids.
“There are a lot of open questions, such as ‘After the physician prescribes it, will the patient actually watch it at home? After the patient watches the program, will the patient return to the doctor?’” he said.
The entire field of research on patient understanding of risk will have many big, open questions for some time to come, noted Dr. Mulley. Even if a method is found to make all patients perfectly understand the risks of an intervention, they would still have dramatically different perspectives on the statistics.
“If there is a 3% risk of death from a procedure, that 3% might be acceptable to me and wholly unacceptable to you,” Dr. Mulley said. “Often medical decisions depend more on those subjective attitudes that a patient brings to a decision than they do on what they learn from the clinical research.”
Put it into practice.
Experts in patient decision-making broke down their experience and research into tips for better communicating with patients about risk.
Frame statistics negatively and positively. Research on the framing of patient choices has found that patients interpret equivalent statistics very differently when they are framed in terms of survival as opposed to mortality.
“When talking to a patient about the risk of death, you should always flip it around: Your risk is of death is 3 in 1,000, which is the same as saying there are 997 chances that you won’t die,” said Harold C. Sox, MACP, editor of the Annals of Internal Medicine.
When offering patients numbers, use 100 as the denominator. “Unless it’s a very, very small percent, usually we’ll give percents. If it’s less than 1%, we would probably use a number out of 1,000,” said Steve Woloshin, MD, associate professor of medicine at Dartmouth Medical School.
“It’s clear that presenting something out of 100 is much better than the tactic that the American Cancer Society has taken with breast cancer which is 1 out of x people,” said Stacey L. Sheridan, ACP Member and assistant professor of medicine at the University of North Carolina.
Metaphors and images can make risk more tangible. “You can imagine an urn with a thousand balls in it, and three of them are black, and if you get the black ball, that means you are destined to have kidney trouble,” Dr. Sox suggested as a hypothetical conversation with a patient.
“For some people, a visual representation of some kind is very helpful,” said Albert Mulley, MD, chief of general medicine at Massachusetts General Hospital. He sometimes uses a graphic that compares the number of women who survive breast cancer with or without additional therapy, for example.
Explain how risk changes over time. If a patient is deciding whether to have surgery for coronary artery disease, it’s important to explain that while the surgery increases the chance of long-term survival, it carries a higher risk of death in the first 30 days, said Dr. Mulley.
The same issues apply when explaining a 10-year risk of cancer recurrence. “That 10-year cumulative risk grows over a 10-year period obviously, but what does the shape of that curve look like? Is it a constant growth over 10 years?” Dr. Mulley asked.
Don’t give too much information. It may sound contrary to all the advice just given, but Dr. Sheridan’s research has found that presenting patients with multiple versions of risk calculations can confuse them. “We throw it out in relative risk terms. We throw in absolute risk terms, and maybe we even throw in the number needed to treat. What happens is that they’re just overwhelmed with all this information,” said Dr. Sheridan.
Giving the information in a take-home written form can mitigate that problem to some degree, she noted, because it means that patients don’t have to absorb all the statistics immediately.
Use decision aids. Much of these experts’ work has gone into the development of decision aids which are available to physicians and patients. Visit these Web sites for more information.
Internist Archives Quick Links
Sign-up for Physician & Practice Timeline® text alerts and never miss another regulatory deadline!
Triggered text alerts aimed at keeping you on top of upcoming deadlines and details related to regulatory, payment, and delivery system requirements are available FREE of charge!
See sign-up instructions.
Pre-order MKSAP17 Complete and Save 15%!
Enter priority code PR58 when ordering. Limited time only. Order now.